Estimating the excess of inappropriate prescriptions of anti-dopaminergic anti-emetics during acute gastroenteritis epidemics in France.
2013
Purpose Anti-dopaminergic
anti-emetics(
ADA) use for the treatment of nausea associated with gastroenteritis (GE) can be considered inappropriate, as their effects are not supported by evidence of clinical efficacy and can potentially induce serious adverse events. Objective This study quantifies the suboptimal consumption of
ADAattributable to seasonal GE epidemics in France and its cost. Methods GE epidemiological data were collected and transmitted by the general practitioners (GPs) of Sentinelles network. Epidemic periods were identified by periodic regression. Drug sales data were obtained from pharmacies, and costs data were obtained from the French National Social Security. The
ADAuse and costs incurred by seasonal GE epidemics were calculated. Results During the epidemic periods considered in this study, the median age of patients seen by GPs for GE was 24 years old. During each epidemic, a sale increase by 14% for
domperidone, by 15% for
metoclopramideand 30% for
metopimazinewas observed. The
average costattributable to seasonal GE epidemic was 5 030 000 Euros, of which 2 160 000 Euros were incurred by the French National Social Security. Conclusion Linking epidemiological databases helped to identify and quantify inappropriate
ADAprescriptions. GE treatment guidelines should be disseminated more widely. Copyright © 2013 John Wiley & Sons, Ltd.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
19
References
7
Citations
NaN
KQI